Navigation Links
Abbott 'Goes Red' to Educate Bay Area Women About Heart Disease
Date:2/1/2008

Abbott Sponsors American Heart Association's 'Go Red for Women' Movement in

the Bay Area

SANTA CLARA, Calif., Feb. 1 /PRNewswire/ -- As a leader in cardiovascular treatment and the exclusive Bay Area "hometown" partner for the national "Go Red for Women" program, Abbott (http://www.abbott.com) is partnering with the American Heart Association (AHA) to raise awareness about heart disease, the leading cause of death for women in America.

One out of every three American women will die of heart disease, yet, according to AHA, only 13 percent of women believe heart disease is their greatest health risk. While largely preventable, heart disease in women often goes underdiagnosed and undertreated. Data shows that most women fail to make the connection between risk factors like high blood pressure and high cholesterol and their risk of developing heart disease.

Through this year-long campaign, which kicks off in February -- American Heart Month -- Abbott and AHA hope to raise awareness that even women without classic risk factors and symptoms may be at risk -- just ask Michelle Smietana, a software testing engineer at Abbott. Ironically, Michelle just had her blood pressure and cholesterol checked -- both were normal. While she used to smoke and had been a bit overweight, she was feeling strong and healthy so she didn't know what to suspect last spring when she experienced some back pain that crept into her neck. At just 33, both she and the cardiologist who treated her were shocked when her ultrasound results showed evidence of a heart attack.

"If heart disease can happen to me, it can happen to anyone. I was only

33, had low cholesterol and good blood pressure. I didn't have the

"normal" symptoms you associate with heart disease like left arm pain and

pressure in my chest. Going through cardiac rehabilitation helped make

exer
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Abbott to Present at Merrill Lynch Healthcare Conference
2. Abbotts Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA
3. Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2007 Earnings
4. Cookie Johnson and Abbott Bring I Stand With Magic: Campaign to End Black AIDS to Los Angeles to Educate African-American Women on HIV/AIDS
5. Ugandan Children Are Among the First to Receive Abbotts Lower-Strength Aluvia (lopinavir/ritonavir) Tablet
6. The Magic Johnson Foundation and Abbott Expand Focus of Campaign to End Black AIDS to African-American Women in 2008
7. FDA Advisory Committee Recommends Approval of Abbotts XIENCE(TM) V Drug Eluting Stent System
8. Abbotts Environmental Protection Initiatives Again Recognized by the State of Illinois
9. Abbott Employees Give Back to Local Communities This Holiday Season
10. AUDIO from Medialink and Abbott Labs: Easing Holiday Stress for Families of Those With Diabetes
11. Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009).../--Withcoldandfluseasonuponus,it,smoreimportanttha...ctionsandavoidillness. ,, "Weneedtobeproactiven...gillnessifwe,resick,"saidEileenFinerty,RN,MS,CIC(c...ectioncontrolandoccupationalhealthatHospitalforSpe...ialSurgeryhasoneofthelowestinfectionratesofanyhosp...
(Date:11/26/2009)...ewswire/--ThediabetespopulationintheUnitedStateswi...endingonthediseaseisprojectedtohit$336billion,upfr...Decemberissueof DiabetesCare .TheNational Changing...,commissionedtheanalysisbyateamfromtheUniversityof...mericanslivingwithdiabeteswillrisefrom23.7millioni...
(Date:11/26/2009)...r of Americans living with diabetes will nearly do... million in 2034. Over the same period, spending o...llion to $336 billion, even with no increase in th...University of Chicago report in the December issue...diabetes covered by Medicare will rise from 8.2 mi...
(Date:11/26/2009)...trathiomolybdate (TM) has been shown in studies to...a disease caused by an overload of copper, and cer...little, however, is known about how the drug works...rthwestern University researchers now has provided...re of TM bound to copper-loaded metallochaperones....
(Date:11/26/2009)...vy can lead to strains or worse , , THUR...hing wrong with stuffing your turkey full to burst...ith your suitcase as you pack for holiday trips. ,...n U.S. hospital emergency rooms, doctors, offices,...related injuries, such as muscle strains, pulls an...
Breaking Medicine News(10 mins):Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Pack Right for the Holidays to Avoid the ER 2
... Monday stressed the need for inter-state cooperat...feit drugs.// "States should create a good sy...rmation and prepare dossiers on the culprits. They...e Committee meeting here, the minister said the ce...
...Pradesh are coming together to educate Muslims on ...pling disease //on the rise among children belongi...lerics, met here Monday under the aegis of the Rot...s, which face Muslim resistance in several places....
...IH funded clinical trials, the Herbal supplements ... other botanical supplements failed to relieve hot..., who participated in the Herbal Alternatives (HAL...er, did receive significant relief from their hot ...
...e million people worldwide, of whom most are child...e, that has given sleepless nights to sufferers, h... have met its nemesis in the development of a nove...accine which is designed to hamper the development...
...rn babies who develop jaundice soon after birth, i...searchers say that this increases the likelihood o... in life. Such moles are termed melanocytic naevi ...ensure that new borns are given sufficient protect...
...ealth care reform plan in January next year that c... of Pennsylvanians who lack coverage. Governor add...hospital infections etc. The plan, which was u...evelop similar program for children, known as Cove...
Other Medicine News:Health News:Muslim Clerics to Join Hands to Eradicate Polio 2Health News:Herbal Supplements Fail to Relieve Hot Flushes 2Health News:Herbal Supplements Fail to Relieve Hot Flushes 3
(Date:11/26/2009)...ica,Nov.26/PRNewswire/--The2009Frost&SullivanS...euticalMarketispresentedtoCiplaMedproSouthAfricaLi.../prnh/20081117/FSLOGO ) ,, FortheCompanyoftheYe...laMedpro,sperformanceagainstkeycompetitors:growths...essprocesses,productsand/ortechnologiesandleadersh...
(Date:11/25/2009)....25/PRNewswire/--PraxisElectronicMedicalRecordsrec...yPhysicians,(AAFP)FamilyPracticeManagement(FPM)200...ty,healthmaintenance,anddiseasemanagement,allcriti...1amongdoctorsindicatingtheirEMRhadapositiveeffecti...mberoneinthecountryinprovidingexcellenttrainingand...
(Date:11/25/2009)...PRNewswire-FirstCall/--AmericanScientificResources...uncethattheyhaveopenedaregionalmarketingandproduct...eenabletosecurealocationabroad,providinganessentia...futurehealthandsafetyproductsforchildrenandadultst...ousesinventoryinthestateofOhiowheretheywillalsobea...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2American Scientific Resources Inc. Opens Shanghai Location 2Bioniche Pharma and Synerx Pharma Launch Melphalan Hydrochloride for Injection 48373 1Bioniche Pharma and Synerx Pharma Launch Melphalan Hydrochloride for Injection 48373 2Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 1Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 2Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 3Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 4Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 5Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 6Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 7Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 8Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 9Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 10Streamline Health 28R 29 Solutions Reports First Quarter Results 48371 11Wildlife Conservation Society supports worlds first study of egg laying mammal 8776 1Wildlife Conservation Society supports worlds first study of egg laying mammal 8776 2Wildlife Conservation Society supports worlds first study of egg laying mammal 8776 3
...aluate Safety, Efficacy of Novel Cortisol ...ept. 26 DiObex, Inc., a privately held,biotechnol...tics to treat,metabolic diseases, announced today ...inical trial of DIO-902, a novel cortisol synthesi...e 2 diabetes mellitus (T2DM). The Phase 2b multin...
...ive Nasal Spray Dosage form is Patient Friendly ...ry Delivery -, BOTHELL, Wash., Sept. 26 Nastech,...nced today the start of a,Phase 2 clinical trial e...,Spray in approximately 20 patients with type 2 di... evaluating formulations of Insulin Nasal Spray,as...
Other Medicine Technology:DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug 2DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug 3Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes 2Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes 3
...lar Mikro-Tip Pressure Catheters; Millar manufactu...heters for simultaneous high fidelity pressure mea...ing pressure gradients across a valve, between cha...s are made of Polyurethane material (some include ...
...le in the United States dying from Sudden Cardiac ...mended that AEDs be used as a standard of care in ...saving shock during a cardiac arrest, but the Card...ties during and after resuscitation. Plus this com...
...ctomy Catheter is a multi-lumen, over-the-wire thr...nd easy removal of fresh, soft thrombus in dialysi...cient, patient-friendly alternative to surgery and...isting contrast power injector. Fragments and remo...
Thrombex PMT System
Medicine Products: